Global Impact

16,797

Newborns Reached

296

Lives Saved*

1,039

Health Workers Empowered

241

Health Facilities using Bempu

* Lives Saved is based on the number of babies touched by the TempWatch and KangaSling times the incidence of hypothermia in babies (45.5%) times the percentage of hypothermia cases that result in death (3.9%). LANCET suggests 19-42% of all newborn deaths could be averted by thermal management. With a 3% death rate for all newborns, this comes to ~1% reduction for all newborns (however our bracelet is given to LBWs which have a higher death rate). 45.5% is the average from studies assessing the incidence of low-birth weight neonatal hypothermia in pre-discharge and post-discharge settings (Bhatia et. al, 2017 & Mullany et. al, 2015). Further studies must be conducted on ApneBoot to assess lives saved by the device. 


image-bg1.png
 

List of Clinical Studies

 
TempWatch-29.png
 

Sensitivity & Specificity

  • Sensitivity and Specificity Study of BEMPU Bracelet in Detecting Hypothermia in Low Birth Weight Neonates (JIPMER, Pondicherry) 

Mortality Rate Reduction 

  • Hypothermia detection and alert device’s impact on newborn survival in a community setting (National Health Mission, Rajasthan)

  • UNICEF Madhya Pradesh and National Health Mission Madhya Pradesh Feasibility Pilot

Weight Gain Promotion

  • Hypothermia alert device in low birth weight newborns and the effect of kangaroo mother care and weight gain: a randomized control trial (Indira Gandhi Institute of Child Health, Bangalore)

Utility

  • Catching and Reducing Hypothermia in Newborns in Clinical and Home settings in India: Utility of a New Medical Device (St. Philomena’s, Bangalore)

Ongoing Studies

We currently have 5 different ongoing studies in Goa, Hyderabad, Delhi, Belgaum, and Gujarat in private, medical, government hospitals to assess the effect of the TempWatch on weight gain, KMC compliance, and weight loss in very low birthweight, low-birth weight, and low normal birth weight babies.

 
carecradleupdated-07.png
 
  • A novel device for home-based monitoring of high-risk newborns detects complications and reassures parents: Pilot results (Meenakshi Hospital, Shivamogga Institute of Medical Sciences, Vydehi, Karnataka) 

 
 
  • Determine the accuracy and efficacy of ApneBoot in resolving apneas with respect to standard of care – non-randomized comparative study (Niloufer Hospital, Hyderabad)

DOWNLOAD BEMPU HEALTH CLINICAL STUDIES

Name *
Name